ASX Market Close: Woodside advances after beating consensus estimates | August 27, 2024

ASX News Market Summary
27 Aug 2024 17:12 (AEST)

The ASX200 closed down 0.17% at 8,071 points as the market awaits local inflation data for July tomorrow.

Energy finished the strongest performer up around 2.3%, followed by Materials around 0.8%. Information Technology shed around 1.3%, Financials was down nearly 0.9% and Industrials down around 0.7%

From Canberra today, news Australia is capping the number of international student arrivals. This may put further pressure on some education stocks throughout the week.

In the Green

Coles (ASX:COL) closed up 1.9% after releasing FY24 financials. This finishes a year where the company outperformed its rival Woolworths (ASX:WOW).

Revenue increased 5.7% to $43.6 billion on the back of strong grocery sales.

Underlying profit after costs rose 4.1% to $1.2 billion.

Coles closed at $18.81.

Woodside (ASX:WDS) closed up more than 4.1% after sharing first half results. Despite a 19% decline in revenue, investors reacted favourably to the news. The highlight was an 11% jump in net profit after tax. In the background, Brent Crude has climbed 5% week on week.

Woodside closed at $27.48

Strike Energy (ASX:STX) has finished the day up around 20% after updating the market on its Erregulla Deep-1 well. Mud gas responses were clocked on the way to a total depth higher than background levels.

Strike Energy closed at 19.8 cents.

In the Red

Fast fashion retailer Lovisa Holdings Ltd (ASX:LOV) closed down around 12% on FY24 results. The stock beat a hasty retreat despite net profit after tax increasing 21%.

Lovisa Holdings pulled up stumps at $32.83.

Sunshine Metals Ltd (ASX:SHN) saw its share price fall 7.7% on news it has sold the Triumph Gold Project in Queensland to Dart Mining for $2 million, evenly split into cash and scrip.

Sunshine Metals closed at 1.2 cents.

Race Oncology (ASX:RAC) closed down around 7% after announcing annual results. The company’s results did not meet expectations and investors swiftly sold off the stock.

Race Oncology closed at $1.61.


arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.